University of Tübingen researchers reverse the evolution of a class of antibiotics to gain in-sights for the development of new drugs. Illustration: Anna Voigtländer.
University of Tübingen researchers reverse the evolution of a class of antibiotics to gain in-sights for the development of new drugs. Illustration: Anna Voigtländer. In today's medical landscape, antibiotics are pivotal in combatting bacterial infections. These potent compounds, produced by bacteria and fungi, act as natural defenses against microbial attacks. A team of researchers delved into the intricate world of glycopeptide antibiotics - a vital resource in countering drug-resistant pathogens - to uncover their evolutionary origins. Dr. Demi Iftime and Dr. Martina Adamek headed this interdisciplinary project, guided by Professors Evi Stegmann and Nadine Ziemert from the "Controlling Microbes to Fight Infections" Cluster of Excellence at the University of Tübingen, with support from Professor Max Cryle and Dr. Mathias Hansen from Monash University in Australia. Using advanced bioinformatics, the team sought to decipher the chemical blueprint of ancient glycopeptide antibiotics.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
